致耐受性的
Alemtuzumab, a humanized anti-CD52 antibody, has shown promise in tolerogenic induction protocols, requiring minimal maintenance immunosuppression. 阿仑单抗
tolerogenic antigen 致耐受性抗原
tolerogen 耐受原(核)
tolerogen(toleragen) 耐受原
致耐受性
